WallStreetZenWallStreetZen

NASDAQ: FUSN
Fusion Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

FUSN past revenue growth

How has FUSN's revenue growth performed historically?
Company
41.55%
Industry
145.73%
Market
17.2%
FUSN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
FUSN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
FUSN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

FUSN earnings and revenue history

Current Revenue
$2.1M
Current Earnings
-$94.9M
Current Profit Margin
-4,588.8%

FUSN Return on Equity

Current Company
-46.6%
Current Industry
-63.5%
Current Market
188%
FUSN's Return on Equity (-46.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when FUSN announces earnings.

FUSN Return on Assets

Current Company
-35.3%
Current Industry
2.9%
FUSN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

FUSN Return on Capital Employed

Current Company
-32.99%
Current Industry
19.5%
FUSN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FUSN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
FUSN$2.07M-$85.08M-$94.90M+19.84%N/A
GPCR$0.00-$88.46M-$89.62MN/AN/A
RXRX$44.58M-$299.66M-$328.07M+109.39%N/A
AGIO$26.82M-$334.75M-$352.09M-22.25%N/A
BEAM$377.71M-$111.15M-$132.53M+1,103.57%N/A
View Top Biotech Stocks

FUSN earnings dates

Next earnings date
Jun 13, 2024

Fusion Pharmaceuticals Earnings & Revenue FAQ

What were FUSN's earnings last quarter?

On Invalid Date, Fusion Pharmaceuticals (NASDAQ: FUSN) reported Q4 2023 earnings per share (EPS) of -$0.39, up 29.09% year over year. Total Fusion Pharmaceuticals earnings for the quarter were -$28.18 million. In the same quarter last year, Fusion Pharmaceuticals's earnings per share (EPS) was -$0.55.

If you're new to stock investing, here's how to buy Fusion Pharmaceuticals stock.

What was FUSN's earnings growth in the past year?

As of Q2 2024, Fusion Pharmaceuticals's earnings has grown year over year. Fusion Pharmaceuticals's earnings in the past year totalled -$94.90 million.

What is FUSN's earnings date?

Fusion Pharmaceuticals's earnings date is Invalid Date. Add FUSN to your watchlist to be reminded of FUSN's next earnings announcement.

What was FUSN's revenue last quarter?

On Invalid Date, Fusion Pharmaceuticals (NASDAQ: FUSN) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Fusion Pharmaceuticals's revenue was $140.00 thousand.

What was FUSN's revenue growth in the past year?

As of Q2 2024, Fusion Pharmaceuticals's revenue has grown 41.55% year over year. This is 104.19 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Fusion Pharmaceuticals's revenue in the past year totalled $2.07 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.